FPR1

Across TCGA pan-cancer cohorts, FPR1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated FPR1 data layer compared with 26 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher FPR1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated FPR1 expression acts as an unfavorable survival marker, although some lineages such as LSCC show a favorable association.

PDAC, LSCC, and LUAD are the cancer types where FPR1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Median	All	0.244	0.700	.001	33	view →
LSCC	DFS	Tertile	III,IV	0.908	0.338	.004	12	view →
LUAD	DFS	Quartile	II,III,IV	0.208	0.822	.018	3	view →
GBM	OS	Median	All	0.451	0.632	.036	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

FPR1–PDAC (OS)

Open the PDAC breakdown →